Open Call: Apply for TRANSVAC2 Vaccine Development Services Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at...
FIND and BIOASTER collaborate on clinical research to assess duration of immune response in patients with COVID-19 Studies will assess whether there is an association between detection of COVID-19 antibodies...
Register to #I4ID2020 Deadline to Early bird registration has been extended to October 30th! Registration, Program and sponsor information: https://www.i4id.org/ #infectiousdiseases #immunotherapies MabDesign Network Lyonbiopôle
MEET US AT THE INTEGRATIVE WORKSHOP ON PROTEOMICS AND METABOLOMICS Thursday October 8 2020, by visio conference BIOASTER will participate the 3rd Integrative Workshop on Proteomics and Metabolomics, 08 October...
PRE-PRINT COVID19: Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 in vitro infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19 Authors: Douglas...
BIOASTER first shareholder with its two co-founders Adama OUATTARA and Wassim ABOU-JAOUDE of Gencovery. Wishing success to the first BIOASTER start-up. Gencovery provides cutting-edge software based on digital organisms for...
Authors: Ouattara DA, Remolue L, Becker J, Perret M, Bunescu A, Hennig K, Biliaut E, Badin A, Giacomini C, Reynier F, Andreoni C, Béquet F, Lecine P, De Luca K. Poult Sci. 2020 Sep;99(9):4360-4372....
Discover our new @BIOASTER publication in @PoultrySci We are really happy to share our new publication in @PoultrySci. This #Multiomics study, combining #Metabolomics and #Transcriptomics, aims at deciphering the pathways...
To accelerate and strenghen their research capabilities dedicated to fight infectious disease. Evotec SE and the French-based BIOASTER Technological Research Institute today announced that they have entered into a partnership...
“Caecal microbiota compositions from 7-day-old chicks reared in high-performance and low-performance industrial farms and systematic culturomics to select strains with anti-Campylobacter activity”. See the article This work carried out in...
A droplet #microfluidics technology has been developed to measure #proteinsecretion kinetics from #singlecells. This technology has been successfully used to characterize monocyte anergy in septic shock patients. SharedIt link
By continuing browsing this website, you accept the use of cookies or other tracers for statistics of visits to optimize the functionality of the site, and or privacy policy. AcceptRejectRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
